BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST

被引：0
|
作者：
Ephrem, Georges [1 ]
Guenoun, Jonathan [1 ]
Kim, Michael [1 ]
Jauhar, Rajiv [1 ]
Meraj, Perwaiz [1 ]
机构：
[1] North Shore LIJ Hlth Syst, Hofstra North Shore LIJ Sch Med, Manhasset, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60115-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1139-094
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [21] Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials
    Cassese, Salvatore
    Byrne, Robert A.
    Laugwitz, Karl-Ludwig
    Schunkert, Heribert
    Berger, Peter B.
    Kastrati, Adnan
    EUROINTERVENTION, 2015, 11 (02) : 196 - 203
  • [22] OUTCOMES OF BIVALIRUDIN VERSUS HEPARIN ALONE IN PERCUTEANEOUS CORONARY INTERVENTION
    Chaudry, H. I.
    Andrus, B. W.
    Bhatt, D.
    DeVries, J. T.
    CARDIOLOGY, 2015, 131 : 223 - 223
  • [23] Comparison of Bivalirudin Monotherapy Versus Unfractionated Heparin Plus Tirofiban in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention
    Tavano, Davide
    Visconti, Gabriella
    D'Andrea, Davide
    Focaccio, Amelia
    Golia, Bruno
    Librera, Mariateresa
    Caccavale, Mario
    Ricciarelli, Bruno
    Briguori, Carlo
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (09): : 1222 - 1228
  • [24] Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction
    Faulkenberg, Kathleen D.
    Beavers, Janna C.
    Finks, Shannon W.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (02) : 141 - 151
  • [25] META-ANALYSIS COMPARING BIVALIRUDIN VS HEPARIN-MONOTHERAPY ON ISCHEMIC AND BLEEDING OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION
    Bertrand, O. F.
    Jolly, S. S.
    Rao, S.
    Patel, T.
    Belle, L.
    Bernat, I.
    Parodi, G.
    Costerousse, O.
    Mann, T.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S312 - S313
  • [26] Bivalirudin vs heparin in percutaneous coronary intervention: A pooled analysis
    Ebrahimi, R
    Lincoff, AM
    Bittl, JA
    Chew, D
    Wolski, K
    Wadhan, N
    Toggart, EJ
    Topol, EJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 10 (04) : 209 - 216
  • [27] Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article
    Wang, Guiping
    Qi, Kaijie
    Li, Xuyang
    Zuo, Shuping
    Zhang, Ruolin
    Zhao, Yanan
    Sun, Suya
    Zhang, Juanjuan
    Liu, Xiaokun
    CARDIOVASCULAR THERAPEUTICS, 2024, 2024 (01)
  • [28] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN: DIFFERENTIAL BENEFIT ACROSS THE SPECTRUM OF PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A118 - A118
  • [29] Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
    Cavender, Matthew A.
    Sabatine, Marc S.
    LANCET, 2014, 384 (9943): : 599 - 606
  • [30] Heparin monotherapy for percutaneous coronary intervention?
    Lincoff, A. Michael
    LANCET, 2014, 384 (9943): : 564 - 566
12345